HM Payson & Co’s Core Laboratories CLB Stock Holding History

HM Payson & Co’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-761	Closed	-$29K	–	910
2019 Q4	$29K	Sell	761 -59	-7%	-$2.65K	﹤0.01%	667
2019 Q3	$38K	Sell	820 -121	-13%	-$5.63K	﹤0.01%	636
2019 Q2	$49K	Buy	+941	New	+$55.2K	﹤0.01%	606

Other funds holding CLB

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

HM Payson & Co's CLB Position: Q1 2020 in Review

HM Payson & Co sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 761 shares — an estimated $29K sold.

HM Payson & Co first reported a position in CLB in Q2 2019 and held it in 3 quarters. The position peaked at $49K in Q2 2019. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

HM Payson & Co reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
HM Payson & Co sold 761 Core Laboratories shares in Q1 2020, an estimated $29K.
HM Payson & Co first reported a position in Core Laboratories in Q2 2019 and held it in 3 quarters.
HM Payson & Co's Core Laboratories position peaked at $49K in Q2 2019.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on HM Payson & Co's 13F filing for Q1 2020, filed 1 Jul 2020.